Cargando…
Impacts of different methylprednisolone administration routes in patients with sudden hearing loss or Meniere’s disease
BACKGROUND: Evidence suggests that glucocorticoids are important in the treatment of sudden hearing loss (SHL) and Meniere’s disease (MD). However, different glucocorticoid administration methods may have a significant impact on treatment outcomes. OBJECTIVE: This study aimed to investigate effects...
Autores principales: | Chen, Dan, Li, Zhipeng, Zhou, Qilin, Chen, Yubin, Yang, Luoying, Tan, Jingqian, Zeng, Xiangli, Li, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese PLA General Hospital
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691840/ https://www.ncbi.nlm.nih.gov/pubmed/33293916 http://dx.doi.org/10.1016/j.joto.2020.08.003 |
Ejemplares similares
-
Intratympanic Methylprednisolone as Rescue Therapy in Sudden Sensorineural Hearing Loss
por: Raymundo, Igor Teixeira, et al.
Publicado: (2015) -
Experimental animal models of drug-induced sensorineural hearing loss: a narrative review
por: Lin, Xuexin, et al.
Publicado: (2021) -
Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss
por: Berjis, Nezamoddin, et al.
Publicado: (2016) -
Optimal Dosage of Methylprednisolone for the Treatment of Sudden Hearing Loss in Geriatric Patients: A Propensity Score-Matched Analysis
por: Choi, Myoung Su, et al.
Publicado: (2014) -
Chronic kidney disease is associated with increased risk of sudden sensorineural hearing loss and Ménière’s disease: a nationwide cohort study
por: Kim, Jong-Yeup, et al.
Publicado: (2021)